We previously reported that systemic injection of MPHh+ corrects angiotensin-II-induced hypertension and endothelial dysfunction in mice68, and exerts cardioprotection against ischemia reperfusion injuries in pigs31. This evidence concerns the gene AGT and endothelial dysfunction.